229 related articles for article (PubMed ID: 24121061)
21. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Koprich JB; Campbell NG; Lipton JW
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
[TBL] [Abstract][Full Text] [Related]
22. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
Kindlundh-Högberg AM; Zhang X; Svenningsson P
Int J Neuropsychopharmacol; 2009 Mar; 12(2):201-15. PubMed ID: 18812013
[TBL] [Abstract][Full Text] [Related]
23. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
Ludwig V; Mihov Y; Schwarting RK
Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
[TBL] [Abstract][Full Text] [Related]
24. High-dose MDMA does not result in long-term changes in impulsivity in the rat.
Saadat KS; Elliott JM; Green AR; Moran PM
Psychopharmacology (Berl); 2006 Sep; 188(1):75-83. PubMed ID: 16896956
[TBL] [Abstract][Full Text] [Related]
25. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
26. Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality.
von Ameln N; von Ameln-Mayerhofer A
Addict Biol; 2010 Jan; 15(1):35-44. PubMed ID: 20002021
[TBL] [Abstract][Full Text] [Related]
27. Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice.
Rodríguez-Arias M; Maldonado C; Vidal-Infer A; Guerri C; Aguilar MA; Miñarro J
Psychopharmacology (Berl); 2011 Nov; 218(2):429-42. PubMed ID: 21556804
[TBL] [Abstract][Full Text] [Related]
28. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
29. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
O'Shea E; Granados R; Esteban B; Colado MI; Green AR
Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
[TBL] [Abstract][Full Text] [Related]
30. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
31. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
32. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
[TBL] [Abstract][Full Text] [Related]
33. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
Koprich JB; Chen EY; Kanaan NM; Campbell NG; Kordower JH; Lipton JW
Neurotoxicol Teratol; 2003; 25(5):509-17. PubMed ID: 12972064
[TBL] [Abstract][Full Text] [Related]
34. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
[TBL] [Abstract][Full Text] [Related]
35. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
36. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats.
Aberg M; Wade D; Wall E; Izenwasser S
Neurotoxicol Teratol; 2007; 29(1):37-46. PubMed ID: 17049207
[TBL] [Abstract][Full Text] [Related]
37. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
38. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
Gartside SE; McQuade R; Sharp T
J Pharmacol Exp Ther; 1996 Oct; 279(1):277-83. PubMed ID: 8859004
[TBL] [Abstract][Full Text] [Related]
39. Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA.
Do Couto BR; Rodríguez-Arias M; Fuentes S; Gagliano H; Armario A; Miñarro J; Aguilar MA
Physiol Behav; 2011 Jul; 103(5):585-93. PubMed ID: 21324326
[TBL] [Abstract][Full Text] [Related]
40. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
Hashimoto K; Goromaru T
Fundam Clin Pharmacol; 1990; 4(6):635-41. PubMed ID: 1710592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
